Compare · ARGX vs GRML
ARGX vs GRML
Side-by-side comparison of argenx SE (ARGX) and Greenland Mines Ltd. (GRML): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ARGX and GRML operate in Biotechnology: Biological Products (No Diagnostic Substances) (Health Care), so they compete in similar markets.
- ARGX is the larger of the two at $60.90B, about 1155.9x GRML ($52.7M).
- Over the past year, ARGX is up 9.9% and GRML is down 83.8% - ARGX leads by 93.7 points.
- ARGX has been more active in the news (10 items in the past 4 weeks vs 7 for GRML).
- ARGX has more recent analyst coverage (25 ratings vs 0 for GRML).
- Company
- argenx SE
- Greenland Mines Ltd.
- Price
- -
- $3.85-1.91%
- Market cap
- $60.90B
- $52.7M
- 1M return
- +19.93%
- -40.60%
- 1Y return
- +9.91%
- -83.82%
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- 2022
- News (4w)
- 10
- 7
- Recent ratings
- 25
- 0
argenx SE
argenx SE, a clinical-stage biotechnology company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases, hematology, and cancer. It is developing its lead product candidate, efgartigimod, for the treatment of patients with myasthenia gravis; immune thrombocytopenia in Phase III; pemphigus vulgaris in Phase III; chronic inflammatory demyelinating polyneuropathy in Phase III; and ENHANZE SC in pre-clinical stages. The company is also developing cusatuzumab in Phase II clinical stage in hematological cancer indications; ARGX-117 in phase I clinical trial with therapeutic potential in both orphan and large autoimmune inflammatory diseases; and preclinical products, including ARGX-118 for airway inflammation. Its partnered product candidates include ARGX-112 for treating skin inflammation, ARGX-116 for the treatment of dyslipidemia, and ARGX-115 for cancer immunotherapy, which are in Phase I clinical stages; and ARGX-114 for treating fibrosisand ARGX-119 for treating neuromuscular indications, which are in preclinical stage. The company has strategic partnership with AbbVie S.Ã.R.L. and LEO Pharma A/S; and collaboration agreement with Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands.
Latest ARGX
- SEC Form 6-K filed by argenx SE
- SEC Form 6-K filed by argenx SE
- argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities
- Unnatural Products to be Acquired by argenx for up to $1.15 Billion to Advance Next-Generation Medicines
- Amendment: SEC Form SCHEDULE 13G/A filed by argenx SE
- argenx to Present at Upcoming Investor Conferences
- SEC Form 6-K filed by argenx SE
- argenx Reports Third Quarter 2026 Financial Results and Provides Business Update
- argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026
- SEC Form 6-K filed by argenx SE
Latest GRML
- Greenland Mines Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- SEC Form SCHEDULE 13G filed by Greenland Mines Ltd.
- Greenland Mines Ltd Provides Early Warning Disclosure Regarding AnorTech Inc.
- Greenland Mines Welcomes Greenland Parliament’s Approval of Landmark U.S.-Denmark-Greenland Security Agreement
- SEC Form EFFECT filed by Greenland Mines Ltd.
- SEC Form S-1 filed by Greenland Mines Ltd.
- Greenland Mines Shares Begin Trading on Xetra in Germany
- Greenland Mines Applauds President Trump’s Focus on Greenland Mineral Exploration, Reinforcing Its Importance to U.S. and Allied Security
- Greenland Mines Welcomes EU Selection of Neo Performance Materials’ Silmet 2.0 as Strategic Project; Highlights Sarfartoq’s Potential Role in Secure Transatlantic Rare Earth Supply
- Greenland Mines President Invited to Join Global Business and Policy Leaders at 2026 Arctic Circle Assembly and Mining Roundtable